In the present study, we aim to investigate MACC1 and MET protein expression in melanocytic nevi, primary and metastatic human melanoma samples using immunohistochemistry, and further evaluating the prognostic value of MACC1 and MET, as well as their potential as biomarkers in melanoma. This evidence concerns the gene MACC1 and melanoma.